| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA772476 | F | Concentration required to inhibit PAF-induced maximum aggregation by 50% | Oryctolagus cuniculus | 40 | ALA1134776 | organism-based format | Scientific Literature | |
| 2. | ALA1909163 | B | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | Cavia porcellus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
| 3. | ALA1909164 | B | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 4. | ALA1909165 | B | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | Oryctolagus cuniculus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
| 5. | ALA1909166 | B | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 6. | ALA1909167 | B | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 7. | ALA1909168 | B | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 8. | ALA1909169 | B | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | 871 | ALA1909046 | cell-based format | DrugMatrix | ||
| 9. | ALA1909170 | B | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 10. | ALA1909171 | B | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 11. | ALA1909172 | B | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 12. | ALA1909173 | B | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 13. | ALA1909174 | B | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 14. | ALA1909175 | B | DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 15. | ALA1909176 | B | DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 16. | ALA1909177 | B | DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 17. | ALA1909178 | B | DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) | Rattus norvegicus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
| 18. | ALA1909179 | B | DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine) | Escherichia coli | 871 | ALA1909046 | single protein format | DrugMatrix | |
| 19. | ALA1909180 | B | DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 20. | ALA1909181 | B | DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) | 871 | ALA1909046 | cell membrane format | DrugMatrix |
The page will load shortly, Thanks for your patience!